This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $100,000
MIRA for Adaptive CLinical Evaluation in Depression (MIRACLE-D): Design and Evaluation of an AI-Powered Personalized Virtual Assistant for Depression Care
CIHR · 2026 · Principal investigator
- $823,905
Trauma-focused Responsive AI Using MIRA (TRAUMIRA): Development and Evaluation of a Trauma-Focused AI Conversational Agent for Posttraumatic Stress Disorder Care
CIHR · 2025 · Principal investigator
- $150,000
Co-Designing MIRA: A Community-Based Digital Partner to Support Personalized Depression Care and Advance Health Equity
CIHR · 2025 · Co-investigator
MIRA for Adaptive CLinical Evaluation in Depression (MIRACLE-D): Design and Evaluation of an AI-Powered Personalized Virtual Assistant for Depression Care
Principal investigators: Bhat, Venkat; Gallson, Dave; Greenshaw, Andrew J; Jetly, Rakesh; Lou, Wen-Yi W; Mulsant, Benoit H; Porter, Ken D; Rockwell, Geoffrey M; Selby, Peter L; Sharma, Divya; Zaiane, Osmar R
Keywords: Agentic Ai; Artificial Intelligence; Conversational Agent; Major Depressive Disorder
Trauma-focused Responsive AI Using MIRA (TRAUMIRA): Development and Evaluation of a Trauma-Focused AI Conversational Agent for Posttraumatic Stress Disorder Care
Principal investigators: Bhat, Venkat; Gallson, Dave; Greenshaw, Andrew J; Jetly, Rakesh; Monson, Candice; Porter, Ken D; Rockwell, Geoffrey M; Sharma, Divya; Zaiane, Osmar R
Keywords: Artificial Intelligence; Conversational Agent; Posttraumatic Stress Disorder
Co-Designing MIRA: A Community-Based Digital Partner to Support Personalized Depression Care and Advance Health Equity
Principal investigators: Bhat, Venkat; Porter, Ken D; Greenshaw, Andrew J; Zaiane, Osmar R
Keywords: Artificial Intelligence; Major Depressive Disorder
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin
Principal investigators: Rosenblat, Joshua D; Gallson, Dave; Husain, Muhammad I
Keywords: Clinical Trial; Major Depressive Disorder; Mental Health; Psilocybin-Assisted Therapy; Psychiatry; Psychopharmacology; Psychotherapy; Treatment Resistant Depression
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.